| Action Summary | The Board will adopt regulations to implement SB212 and HB1006 of the 2026 General Assembly Session, which permit TPA-certified optometrists to sell and dispense Schedule VI controlled substances to their own patients provided that the optometrists obtains a license from the Board of Pharmacy and consistent with regulations of the Board of Pharmacy. |
| Chapters Affected | Only affects this chapter. |
| Executive Branch Review | This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication. Exempt Citation: Enactment clause 2 of Chapters 929 and 941 of the 2026 Acts of Assembly. |
| RIS Project | Yes [8796] |
| Associated Mandates |
Bill: HB1006 (2026)
Bill: SB212 (2026)
|
| New Periodic Review | This action will not be used to conduct a new periodic review. |
| Stage ID | Stage Type | Status |
|---|---|---|
| 11279 | Final | Attorney General review in progress. |
| Name / Title: | Caroline Juran, RPh / Executive Director |
| Address: |
9960 Mayland Drive Suite 300 Richmond, VA 23233-1463 |
| Email Address: | caroline.juran@dhp.virginia.gov |
| Phone: | (804)527-4456 FAX: (804)527-4472 TDD: ()- |